The first-ever adaptive clinical trial for Australians living with MS will seek to reverse neurological damage caused by progressive multiple sclerosis.
Two Griffith University research projects have been successful in gaining grants from the Medical Research Future Fund (MRFF) worth a combined $2.7 million.